{"id":"W4412394230","doi":"10.1080/13543784.2025.2532446","title":"Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"Kite Pharma; Chugai Pharmaceutical; Genentech; Juno Therapeutics; Incyte; BeiGene; Adaptive Biotechnologies; Regeneron Pharmaceuticals; Array BioPharma; Karyopharm Therapeutics; Exelixis; Sanofi; GlaxoSmithKline; Johns Hopkins University; Amgen; Pfizer; Legend Biotech; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Multiple myeloma; Current (fluid); Medicine; Intensive care medicine; Immunology; Engineering","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337228,0.0007046803,0.001435467,0.001961653,0.0002150324,0.001179318,0.0009189905,0.001203712,0.006232921],"category_scores_gemma":[0.001660296,0.0002203528,0.00107646,0.002244235,0.000392895,0.001107233,0.0006388896,0.0020761,0.002142407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000721015,"about_ca_system_score_gemma":0.001663275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001496663,"about_ca_topic_score_gemma":0.002958634,"domain_scores_codex":[0.9995789,0.0001074842,0.00005916973,0.00005718264,0.0001592864,0.00003793112],"domain_scores_gemma":[0.9991524,0.0004195504,0.0001677221,0.00001623784,0.0002008288,0.00004323337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001112238,0.00003632452,0.00009878399,0.03662687,0.0002017351,0.00007641104,0.00004356474,0.0002690433,0.0005311791,0.001996702,0.03412653,0.9258816],"study_design_scores_gemma":[0.00007235815,0.000122555,0.0007201507,0.02435687,0.0005134742,0.0006385419,0.00006448901,0.0001227312,0.0002024031,0.002238389,0.9709297,0.00001842747],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003305641,0.9991249,0.00003293715,0.000324118,0.0001122181,0.000003522212,0.00001042899,0.000003596027,0.0003551571],"genre_scores_gemma":[0.0003380898,0.9989684,0.00009848866,0.0002667609,0.000108292,0.000004946361,0.00001884485,9.686182e-7,0.0001952282],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006232921,"threshold_uncertainty_score":0.02085119,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.118589366098917,"score_gpt":0.4678993425352598,"score_spread":0.3493099764363428,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}